Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
71.86
+0.03 (0.04%)
Dec 15, 2025, 4:00 PM EST - Market closed
Avidity Biosciences Employees
Avidity Biosciences had 391 employees as of December 31, 2024. The number of employees increased by 138 or 54.55% compared to the previous year.
Employees
391
Change (1Y)
138
Growth (1Y)
54.55%
Revenue / Employee
$53,371
Profits / Employee
-$1,406,105
Market Cap
10.83B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 391 | 138 | 54.55% |
| Dec 31, 2023 | 253 | 67 | 36.02% |
| Dec 31, 2022 | 186 | 61 | 48.80% |
| Dec 31, 2021 | 125 | 54 | 76.06% |
| Dec 31, 2020 | 71 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
RNA News
- 25 days ago - These 15 stocks are still showing momentum — and a market-beating edge - Market Watch
- 26 days ago - Avidity Biosciences Announces U.S. Managed Access Program (MAP) for Investigational Therapy del-zota in DMD44 - PRNewsWire
- 5 weeks ago - Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights - PRNewsWire
- 6 weeks ago - Here's Why Avidity Biosciences Stock Soared This Week (There's More to the Deal Than You Might Think) - The Motley Fool
- 6 weeks ago - 3 Investable Laggards In An Overbought Market - Seeking Alpha
- 7 weeks ago - Avidity Biosciences Investor Alert By The Former Attorney General Of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Avidity Biosciences, Inc. - RNA - Business Wire
- 7 weeks ago - Why Avidity Biosciences Stock Blasted 42% Higher Today - The Motley Fool
- 7 weeks ago - Avidity Biosciences Soars After $72 Per Share Novartis Takeover - Benzinga